Literature DB >> 7646071

"Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells.

M L Wade1, N F Voelkel, F A Fitzpatrick.   

Abstract

"Suicide" inactivation accompanied catalysis by isolated prostaglandin I synthase. Inactivation occurred via a saturable, pseudo-first-order process with an apparent binding constant Ki = 8 microM prostaglandin H2 and an inactivation rate constant ki = 0.06 s-1. Enzymatic activity declined as an exponential function of substrate concentration and a linear function of product formation. A competitive inhibitor, 9,11-(methanoepoxy)-15(S)-hydroxy-prosta-5Z,13E-dienoic acid, protected the enzyme from inactivation. Prostaglandin H1, an endoperoxide which is not a substrate, inactivated the enzyme less effectively than prostaglandin H2. The differences between inactivation by prostaglandin H2 and H1, the protective effect of the competitive inhibitor, the quantitative similarity between Km and Ki, and the dependence on catalysis all suggest that inactivation originates primarily from a transition-state intermediate, not from malondialdehyde formed by hydrolysis of prostaglandin endoperoxides. Collectively, the data conform to criteria for a specific, mechanism-based process in which a common enzyme-substrate complex participates in two parallel reactions, one leading to turnover and the other to suicide inactivation. Inactivation accompanying catalysis by prostaglandin I synthase in intact endothelial cells was transient, consistent with the cellular capacity for de novo protein synthesis. Enzyme activity returned to the initial steady-state level within 15-20 min, suggesting that prostaglandin I synthase has a half-life < or = 5 min.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646071     DOI: 10.1006/abbi.1995.1417

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase.

Authors:  T Maurer; H L Fung
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Regulated formation of eicosanoids.

Authors:  F A Fitzpatrick; R Soberman
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

3.  Hypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuli.

Authors:  Mercedes Camacho; Cristina Rodríguez; Anna Guadall; Sonia Alcolea; Mar Orriols; José-Román Escudero; José Martínez-González; Luis Vila
Journal:  J Lipid Res       Date:  2011-02-04       Impact factor: 5.922

4.  Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis.

Authors:  Vengai Mavangira; Matthew J Kuhn; Angel Abuelo; Christophe Morisseau; Bruce D Hammock; Lorraine M Sordillo
Journal:  Antioxidants (Basel)       Date:  2021-05-20

Review 5.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

Review 6.  PGI2 as a regulator of inflammatory diseases.

Authors:  Stacy L Dorris; R Stokes Peebles
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

7.  Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis.

Authors:  S A Mattmiller; Bradley A Carlson; L M Sordillo
Journal:  J Nutr Sci       Date:  2013-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.